Core Viewpoint - A class action lawsuit has been filed against China Liberal Education Holdings Limited (CLEU) for alleged securities fraud and unlawful business practices [2]. Group 1: Lawsuit Details - The lawsuit claims that CLEU and certain officers and/or directors engaged in securities fraud [2]. - Investors have until March 31, 2026, to request to be appointed as Lead Plaintiff if they purchased CLEU securities during the Class Period [2]. - A complaint alleges that in January 2025, individuals impersonating investment advisors on social media influenced investors to buy CLEU stock, artificially inflating its price [4]. Group 2: Impact on Investors - On January 30, 2025, the stock price of CLEU suddenly dropped, resulting in significant losses for many investors who had purchased shares [4]. - The lawsuit aims to address the financial damages suffered by investors due to the alleged fraudulent activities [2][4]. Group 3: Law Firm Background - Pomerantz LLP, the firm handling the case, is recognized for its expertise in corporate, securities, and antitrust class litigation, having recovered numerous multimillion-dollar damages for class members [5].

Core Viewpoint - A class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. for alleged securities fraud and unlawful business practices, with investors encouraged to join the lawsuit [1][2]. Group 1: Lawsuit Details - The class action lawsuit concerns whether Ultragenyx and certain officers and/or directors engaged in securities fraud or other unlawful business practices [2]. - Investors have until April 6, 2026, to request to be appointed as Lead Plaintiff if they purchased Ultragenyx securities during the Class Period [2]. Group 2: Stock Performance and Events - On July 9, 2025, Ultragenyx announced progress in the Phase 3 Orbit study for UX143, leading to a stock price drop of $10.41 per share, or 25.11%, closing at $31.04 on July 10, 2025 [4]. - On December 29, 2025, Ultragenyx reported that its Phase III Orbit and Cosmic Studies failed to achieve statistical significance, resulting in a stock price decline of $14.47 per share, or 42.32%, closing at $34.19 [5].

Core Viewpoint - A class action lawsuit has been filed against BlackRock TCP Capital Corp. for alleged securities fraud and unlawful business practices [2]. Group 1: Lawsuit Details - Investors are encouraged to contact Pomerantz LLP for participation in the class action, with a deadline to apply as Lead Plaintiff by April 6, 2026 [2]. - The lawsuit claims that BlackRock TCP and its officers engaged in fraudulent activities related to their securities [2]. Group 2: Financial Performance - On February 27, 2025, BlackRock TCP reported that the number of portfolio companies on non-accrual status had more than doubled, and its net asset value (NAV) fell over 22% year-over-year to $9.23 per share, leading to a 9.6% drop in stock price [4]. - On January 23, 2026, BlackRock TCP disclosed that its NAV per share was actually between $7.05 and $7.09, which was 19% lower than the previous quarter and 23.4% lower than the previous year, resulting in a nearly 13% decline in stock price [5].

Core Viewpoint - A class action lawsuit has been filed against Picard Medical, Inc. for alleged securities fraud and unlawful business practices [2][4]. Group 1: Lawsuit Details - The lawsuit involves allegations that Picard and certain officers and/or directors engaged in securities fraud [2]. - Investors have until April 3, 2026, to request to be appointed as Lead Plaintiff if they purchased Picard securities during the Class Period [2]. Group 2: Stock Price Surge - Picard's stock price increased from its IPO price of $4.00 per share to an all-time high of $13.68 per share before October 23, 2025, without any fundamental news to justify this increase [4]. - Investigations revealed that the stock price surge was due to an illicit social-media promotion scheme that falsely inflated the stock price through misleading claims by impersonators posing as financial advisors [4]. Group 3: Law Firm Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of fighting for victims of securities fraud and corporate misconduct [5]. - The firm has a track record of recovering multimillion-dollar damages for class members [5].

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against REGENXBIO Inc. (“Regenxbio” or the “Company”) (NASDAQ: RGNX).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.  The class action concerns whether Regenxbio and certain of it ...

Core Viewpoint - A class action lawsuit has been filed against Ostin Technology Group Co., Ltd. for alleged securities fraud and unlawful business practices, with significant investor losses reported [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Ostin and certain officers/directors engaged in a securities fraud scheme that resulted in over $950 million in market capitalization losses for investors [2][4]. - Investors have until April 17, 2026, to request to be appointed as Lead Plaintiff if they purchased Ostin securities during the Class Period [2]. Group 2: Financial Impact - The fraudulent activities reportedly inflated Ostin's market capitalization from approximately $22 million (stock price of $0.78 on April 14, 2025) to over $1 billion (peak stock price of $9.40 on June 26, 2025) [4]. - On June 26, 2025, Ostin's stock experienced a dramatic selloff, leading to a loss of over $950 million, which is more than 94% of its market capitalization, as the stock price fell from an intraday high of $9.40 to a closing price of $0.55 [5].

On September 4, 2024, Lakeland released second quarter 2025 financial results, reporting revenue of $38.51 million, missing consensus estimates by $1.39 million, due to "shipment timing†and delayed orders. On this news, Lakeland's stock price fell $1.86, or 7.8%, to close at $21.92 per share on September 5, 2024, thereby injuring investors. Then, on April 9, 2025, Lakeland released fourth quarter and full year 2025 financial results, again missing consensus estimates and its own guidance, due to "a large Jo ...

Core Viewpoint - A securities fraud class action lawsuit has been filed against NuScale Power Corporation for misleading statements regarding its commercialization strategy and financial performance during a specific period [2][4][7]. Company Overview - NuScale Power Corporation (NYSE: SMR) is facing legal action due to allegations of false and misleading statements made between May 13, 2025, and November 6, 2025 [2][7]. - The lawsuit is filed in the United States District Court for the District of Oregon, under the case caption Truedson v. NuScale Power Corporation, et al [2]. Financial Performance - In the third fiscal quarter of 2025, NuScale reported a significant increase in general and administrative expenses, which rose over 3,000% to $519 million from $17 million in the prior year [5]. - The company's quarterly net loss surged to $532 million, compared to a loss of $46 million in the same period the previous year [5]. Allegations Summary - The complaint alleges that NuScale misrepresented the capabilities of ENTRA1 Energy LLC, claiming it had experience in nuclear power generation, which it did not possess [4]. - It is claimed that NuScale's commercialization strategy was exposed to undisclosed risks, including potential failures and regulatory challenges [4]. Investor Actions - Investors who purchased NuScale Class A common stock during the specified period are encouraged to file for lead plaintiff status by April 20, 2026 [6][8]. - Kessler Topaz Meltzer & Check, LLP is the law firm representing the investors and offers free consultations regarding the case [3][9].

Core Viewpoint - A class action lawsuit has been filed against Enphase Energy, Inc. and certain officers for alleged violations of federal securities laws during the Class Period from April 22, 2025, to October 28, 2025, seeking damages for affected investors [1]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the Northern District of California, seeking remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who acquired Enphase securities during the Class Period have until April 20, 2026, to request appointment as Lead Plaintiff [2]. Group 2: Company Overview - Enphase Energy, founded in March 2006, specializes in solar generation, storage, and communication solutions, partnering with financing companies to offer third-party ownership arrangements for solar and battery products [4]. - The company reported "safe harbor revenue," defined as sales to customers planning to install products over more than a year [4]. Group 3: Tax Credit Context - The Residential Clean Energy Credit allowed homeowners to deduct 30% of costs for clean energy property installed at their homes [5]. - The 25D Credit was set to terminate on December 31, 2025, seven years earlier than originally planned, impacting the financial outlook for Enphase [6]. Group 4: Allegations and Financial Impact - The Complaint alleges that Enphase made materially false and misleading statements regarding its business operations, including overstating its ability to manage channel inventory and mitigate the effects of the 25D Credit termination [7]. - Following the announcement of financial results on October 28, 2025, Enphase's management indicated a weak outlook for 2025, with elevated channel inventory and expected revenue impacts from the 25D Credit expiration [8]. - Enphase's stock price fell by $5.56 per share, or 15.15%, closing at $31.14 per share on October 29, 2025, following the news [9].

Core Viewpoint - A class action lawsuit has been filed against Lakeland Industries, Inc. and certain officers for alleged violations of federal securities laws during the Class Period from December 1, 2023, to December 9, 2025, seeking damages for affected investors [1]. Company Overview - Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories globally, employing a "small, strategic, and quick" mergers and acquisitions strategy to drive growth in revenue and profitability [4]. Recent Acquisitions - In November 2023, Lakeland announced the acquisition of Pacific Helmets NZ Limited, a designer and manufacturer of helmets for firefighting and rescue markets, claiming it enhanced Lakeland's product portfolio [5]. - In February 2024, Lakeland acquired Jolly Scarpe S.p.A. and Jolly Scarpe Romania S.R.L., known for professional footwear for firefighting and military markets, which was touted as a significant milestone in Lakeland's expansion efforts [6]. Financial Performance and Guidance - Throughout the Class Period, Lakeland's management consistently represented that the company would benefit significantly from its acquisitions and was well-positioned to handle tariff-related market uncertainties, maintaining confidence in their financial guidance [7]. - In July 2024, management projected adjusted EBITDA for FY 2025 to be between $18 million and $21.5 million, reaffirming expectations of at least $18 million [8]. - In April 2025, management forecasted FY 2026 revenue of $210 to $220 million and adjusted EBITDA of $24 to $29 million, despite tariff-related uncertainties [9]. Allegations of Misleading Statements - The lawsuit alleges that management made materially false and misleading statements regarding Lakeland's business operations and prospects, including issues with the Pacific Helmets and Jolly businesses, which were not disclosed [10][11]. - Specific issues cited include shipping delays, production problems, and a deterioration in financial results due to tariff-related headwinds and operational challenges [11]. Stock Price Impact - Following the release of disappointing financial results, Lakeland's stock price experienced significant declines, including a drop of 7.82% after Q2 FY 2025 results missed estimates [12]. - Subsequent financial disclosures in April 2025 and June 2025 led to further stock price declines of 14.33% and 22.16%, respectively, as management cited production issues and tariff-related delays [13][14]. - On December 9, 2025, after announcing Q3 FY 2026 results and withdrawing financial guidance, Lakeland's stock fell by 38.97% [16][17].